Petco Health and Wellness Company, Inc. (WOOF) has reiterated its financial outlook for fiscal year 2026, maintaining its projections for net sales and adjusted EBITDA. The company expects FY2026 net sales to range from flat to an increase of 1.5%. Concurrently, Petco reaffirmed its adjusted EBITDA guidance for the same period, targeting figures between $415 million and $430 million.
Q1 Performance and Strategic Validation
The reaffirmation of these targets comes as Petco reported positive comparable sales for the first quarter of fiscal year 2026. This performance was highlighted during the company’s Q1 2026 management view, providing what CEO & Director Joel Anderson described as an “encouraging early validation” of their ongoing strategic initiatives.
Anderson specifically noted, “Our strong Q1 results provide an encouraging early validation of our Phase III Reach for the Sky strategy.” This statement underscores management’s confidence in the effectiveness of its current business strategy, particularly in light of the positive shift in comparable sales, a key metric for retail health.
The positive Q1 comparable sales are a critical indicator, suggesting a potential turnaround or stabilization in customer demand and operational efficiency for Petco. The reaffirmed FY2026 guidance, anchored by these early positive results, signals management’s belief in its ability to navigate the current market environment and achieve its long-term financial objectives.
